?

Therapy Market Research Reports & Industry Analysis

Defined as treatment of disabilities/illnesses (physical and mental), therapy represents an essential branch of medicine. This term is widely used by psychologists to describe the session between them and patients. Depending on an illness, different therapies types are applied. Therapies may be aimed at the prevention of the disease occurrence, stopping its further progress or preventing an outbreak. They may be also used to improve a patient’s comfort.

Therapies are classified on the basis of energy (e.g. phototherapy and thermotherapy), human interaction (for instance, psychotherapy and psychotherapy) and matter (e.g. gene therapy and biotherapy), etc.

The Catalogue is an unprecedented source of research reports analyzing the therapy market in detail. The reports uncover the market sizing and segmentation, its present standing and future prospects. The research studies investigate the competitive environment and contain majors’ profiles. Market igniters and limiters are scrutinized, and trends and future opportunities are unveiled in the reports.

Found 3611 publications
Global and Chinese Proton Therapy System Industry, 2015 Market Research Report US$ 2,800.00

The 'Global and Chinese Proton Therapy System Industry, 2010-2020 Market Research Report' is a professional and in-depth study on the current state of the global Proton Therapy System ... project of Proton Therapy System Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2010-2020 global and Chinese Proton Therapy System industry ...

Jun, 2015 150 pages
Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 US$ 2,500.00

... to any traumatic event, and it drains a person emotionally. According to the DSM-IV codes found in the Diagnostic and Statistical Manual of Mental Disorders, ... during the course of the treatment. Technavio's analysts forecast the global PTSD therapeutics market to grow at a CAGR of 1.09% over the period 2014- ...

Jun, 2015 71 pages
Posterior Uveitis - Pipeline Review, H1 2015 US$ 2,000.00

Posterior Uveitis - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Posterior Uveitis - Pipeline Review, H1 2015’, provides an overview of the Posterior Uveitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Posterior Uveitis ...

May, 2015 57 pages
Osteonecrosis - Pipeline Review, H1 2015 US$ 2,000.00

... Osteonecrosis - Pipeline Review, H1 2015’, provides an overview of the Osteonecrosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Osteonecrosis, complete with comparative analysis at various stages, therapeutics assessment ...

May, 2015 42 pages
North America Therapy Wound Care Devices Market by Type (NPWT, Pressure Relief Devices, Hyperbaric Oxygen Therapy), by End-User (In-Patient Facilities, Out-Patient Facilities), by Country... US$ 2,650.00

... U.S. led the North American therapy wound care devices market, followed by Canada and Mexico. Canada is the fastest-growing market in the North American therapy wound care devices market ... and strengthen their position in the North American therapy wound care devices market. The key players in the North American therapy wound care devices market are Kinetic Concepts ...

May, 2015 124 pages
US Proton Therapy Market Outlook 2020 US$ 2,000.00

... number of proton therapy centers. Hence, many research institutions and hospitals have started investing in proton therapy to make it more accessible to patients. According to the “US Proton Therapy Market Outlook 2020”, report by RNCOS, the United States will be home to 29 such centers by 2020. Consequently, the market will ...

Jun, 2015 75 pages
Venous (Vein) Thrombosis - Pipeline Review, H1 2015 US$ 2,000.00

... Vein) Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Venous (Vein) Thrombosis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Venous (Vein) Thrombosis, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 90 pages
Primary Immune Deficiency (PID) - Pipeline Review, H1 2015 US$ 2,000.00

... PID) - Pipeline Review, H1 2015’, provides an overview of the Primary Immune Deficiency (PID)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Primary Immune Deficiency (PID), complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 67 pages
Keratitis - Pipeline Review, H1 2015 US$ 2,000.00

... Keratitis - Pipeline Review, H1 2015’, provides an overview of the Keratitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Keratitis, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 70 pages
Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation US$ 6,995.00

... Summary Highly Innovative and Diverse Pipeline The Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD) pipeline consists of 84 molecules across all stages of development ...

May, 2015 77 pages
Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth US$ 4,995.00

... research, "Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth", which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. For the purposes of this report, APAC refers to the market in China, India, Japan, and ...

May, 2015 91 pages
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation US$ 6,995.00

... proportion of breakthrough innovations is significant. GBI Research analysis identified 59 first-in-class programs in the asthma pipeline, acting on 43 first-in-class molecular targets, accounting ... of a specific asthma phenotype. Its launch therefore addressed a significant unmet need for personalized therapy in asthma. Approximately 60% of asthmatics have allergic asthma, and may ...

May, 2015 67 pages
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs US$ 4,995.00

... leading business intelligence provider, has released its latest research, "Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth ... of Blockbuster Anti-TNFs", which provides in-depth analysis of Rheumatoid Arthritis (RA) market within the Asia-Pacific (APAC) market covering the four countries of Australia, China ...

May, 2015 126 pages
Gastroenteritis - Pipeline Review, H1 2015 US$ 2,000.00

... Gastroenteritis - Pipeline Review, H1 2015’, provides an overview of the Gastroenteritis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastroenteritis, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 50 pages
Bronchitis - Pipeline Review, H1 2015 US$ 2,000.00

... Bronchitis - Pipeline Review, H1 2015’, provides an overview of the Bronchitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Bronchitis, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 45 pages
Global Cell Therapy Market Outlook 2020 US$ 2,400.00

... of Stem Cells in Cell Therapy Global Cell Therapy Market Analysis Global Cell Therapy Clinical Pipeline by Country, Indication & Phase Marketed Cell Therapy Clinical Insight by Brand Name, Company & Indication Global Cell Therapy Clinical Pipeline: 262 Cell Therapies Marketed Cell Therapies: 13 Marketed Cell ...

May, 2015 550 pages
Global Haemophilia Therapeutics Industry 2015 Market Research Report US$ 2,850.00

2015 Global Haemophilia Therapeutics Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Haemophilia Therapeutics industry, focusing on the main ... with: 1.) basic information; 2.) the Asia Haemophilia Therapeutics industry; 3.) the North American Haemophilia Therapeutics industry; 4.) the European Haemophilia Therapeutics industry; 5.) market entry and investment feasibility ...

Apr, 2015 172 pages
Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 US$ 3,995.00

... gren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Sjögren’s Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Sjogren's Syndrome Therapeutics market. The ...

Feb, 2012 59 pages
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations US$ 4,995.00

Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations Summary GBI Research, a ... latest research report, 'Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations'.The asthma therapeutics market is forecast ...

Feb, 2015 142 pages
Aeglea BioTherapeutics Holdings, LLC - Product Pipeline Review - 2015 US$ 1,500.00

... pipeline projects Latest company statement Latest news and deals relating to the Aeglea BioTherapeutics Holdings, LLC ’s pipeline products Reasons to buy Evaluate Aeglea BioTherapeutics Holdings, LLC ...

Mar, 2015 20 pages
Physician Views: What Scope for the Next Oral RA Therapy? US$ 695.00

... of uptake, particularly as many KOLs expected Pfizer's drug to be priced lower. What does the performance and positioning of Xeljanz mean for other ... do you think will be necessary to drive adoption of baricitinib in favour of Xeljanz? What impact do you think availability of a cheaper, once-daily oral treatment ...

Apr, 2015
Physician Views: How Comfortable are Doctors with the Commercial Use of Gene Therapy? US$ 695.00

... safety issues first emerged? To gain better understanding about the views of doctors on the potential of gene therapy, FirstWord PLUS is polling US- and ... launched in Germany at a price of more than 1 million euros ($1.1 million). How concerned are you that gene therapies like this may prove cost ...

Mar, 2015
Physician Views – Defining a Suitable NASH Therapy US$ 695.00

... characteristics for an ideal NASH therapy, as based on KOL feedback. This Physician Views poll uses that summary as inspiration and asks US and EU5 ...

Mar, 2015
Global Proton Therapy Market and Centers Analysis US$ 1,000.00

... proton therapy treatment. The number of proton therapy centers worldwide is anticipated to increase year on year with an ever-increasing number of patients. iGATE RESEARCH report entitled Global Proton Therapy Market ... -growth Proton Therapy Market. This 126 page report with 29 Figures and 10 Tables studies in detail the Global Proton Therapy Market. The Report covers the Global Total Number ...

Dec, 2014 126 pages
Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2015 US$ 2,000.00

... Thrombotic Thrombocytopenic Purpura - Pipeline Review, H1 2015’, provides an overview of the Thrombotic Thrombocytopenic Purpura’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Thrombotic Thrombocytopenic Purpura ...

Mar, 2015 53 pages
Sinusitis - Pipeline Review, H1 2015 US$ 2,000.00

... Sinusitis - Pipeline Review, H1 2015’, provides an overview of the Sinusitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Sinusitis, complete with comparative analysis at various stages, therapeutics assessment ...

Mar, 2015 64 pages
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015 US$ 2,000.00

... Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2015’, provides an overview of the Proliferative Diabetic Retinopathy (PDR)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Diabetic Retinopathy (PDR ...

Mar, 2015 54 pages
Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2015 US$ 2,000.00

... Organophosphate And Carbamate Poisoning - Pipeline Review, H1 2015’, provides an overview of the Organophosphate And Carbamate Poisoning’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Organophosphate And Carbamate Poisoning ...

Mar, 2015 32 pages
Oligodendroglioma - Pipeline Review, H1 2015 US$ 2,000.00

... Oligodendroglioma - Pipeline Review, H1 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Oligodendroglioma, complete with comparative analysis at various stages, therapeutics assessment ...

Mar, 2015 94 pages
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015 US$ 2,000.00

... Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - Pipeline Review, H1 2015’, provides an overview of the Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Inflammatory ...

Mar, 2015 46 pages
Acid Sphingomyelinase Deficiency (Niemann-Pick Disease) - Pipeline Review, H1 2015 US$ 2,000.00

... Deficiency (Niemann-Pick Disease) - Pipeline Review, H1 2015’, provides an overview of the Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acid Sphingomyelinase Deficiency (Niemann-Pick Disease ...

Mar, 2015 55 pages
Pollen Allergy - Pipeline Review, H1 2015 US$ 2,000.00

Pollen Allergy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pollen Allergy - Pipeline Review, H1 2015’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pollen Allergy ...

Mar, 2015 103 pages
Becker Muscular Dystrophy - Pipeline Review, H1 2015 US$ 2,000.00

... Muscular Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Becker Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Becker Muscular Dystrophy’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Becker Muscular ...

Mar, 2015 39 pages
Hormone Replacement Therapy (HRT)-API Insights, 2015 US$ 1,250.00

... Hormone Replacement Therapy (HRT)-API Insights, 2015,report provides Hormone Replacement Therapy (HRT) drugs marketed details and API Manufacturers ...

Apr, 2015 60 pages
Oncogene Inhibitors Therapy Market & Pipeline Insight 2015 US$ 2,400.00

... Oncogene Inhibitors Pipeline: 185 Drugs Majority Oncogene Inhibitors in Preclinical Phase: 105 Drugs Proto Oncogene Protein c met Inhibitors Pipeline: 42 Drugs Proto Oncogene Protein c-akt Inhibitors: 39 Drugs Marketed Oncogene Inhibitors: 22 Drugs Marketed Proto-Oncogene Protein c-bcl-2 Inhibitors: 8 Drugs ...

Apr, 2015 500 pages
Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen... US$ 3,400.00

Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric Antigen Receptor (CAR) T-Cell ... KellySciPub’s latest cutting-edge analysis of the Global & USA Cancer Immunotherapy Market Analysis to 2020” reveals that the cancer immunotherapy space will be a significant revenue generator (excess ...

Apr, 2015 256 pages
Urea World Report US$ 4,250.00

UREA WORLD REPORT The Urea World Report gives Market Consumption/Products/Services for over 200 ... Parameters, Marketing Costs, Markets, Decision Makers, Performance, Product Launch. WORLD & NATIONAL REPORT MARKET DATABASE & SPREADSHEETS. FINANCIAL SPREADSHEETS & DATABASES. INDUSTRY ...

Mar, 2015 2055 pages
Pemphigus - Pipeline Review, H1 2015 US$ 2,000.00

... Pemphigus - Pipeline Review, H1 2015’, provides an overview of the Pemphigus’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pemphigus, complete with comparative analysis at various stages, therapeutics assessment ...

Feb, 2015 68 pages
Aortic Aneurysm - Pipeline Review, H1 2015 US$ 2,000.00

Aortic Aneurysm - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Aortic Aneurysm - Pipeline Review, H1 2015’, provides an overview of the Aortic Aneurysm’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Aortic Aneurysm ...

Feb, 2015 49 pages
Engineered TCR and CAR Immunotherapeutics 2015 US$ 2,630.00 US$ 2,104.00

... Engineered TCR and CAR Immunotherapeutics 2015: A comparative analysis of the landscape of and business opportunities with  TCR and CAR antibodies, T cells, NK cells, TILs, DLIs & CTLs The engineered ... Cellular TCR T Cells CAR T Cells (autologous/allogeneic) Recombinant Bispecific TCR-anti-CD3 (e.g. ImmTACs) Bispecific antibodies (incl. anti-CD3) This report Engineered TCR and CAR Immunotherapeutics ...

Mar, 2015 201 pages
Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019 US$ 3,000.00

... . The major orphan blood diseases that contribute to acquired orphan blood diseases are the following: ITP, MDS, MF PNH, and PV. TechNavio's analysts forecast the Global Acquired Orphan Blood Diseases Therapeutics market to grow ... in the treatment of PNH, ITP, PV, MF, and MDS. TechNavio's report, the Global Acquired Orphan Blood Diseases Therapeutics Market 2015-2019, has been prepared based on an in-depth ...

Mar, 2015 114 pages
Gastroparesis - Pipeline Review, H1 2015 US$ 2,000.00

... Gastroparesis - Pipeline Review, H1 2015’, provides an overview of the Gastroparesis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastroparesis, complete with comparative analysis at various stages, therapeutics assessment ...

Feb, 2015 37 pages
Gastrointestinal Radiation Toxicity - Pipeline Review, H1 2015 US$ 2,000.00

... Gastrointestinal Radiation Toxicity - Pipeline Review, H1 2015’, provides an overview of the Gastrointestinal Radiation Toxicity’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Gastrointestinal Radiation Toxicity ...

Jan, 2015 47 pages
Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015 US$ 2,000.00

... CAD) (Ischemic Heart Disease) - Pipeline Review, H1 2015’, provides an overview of the Chronic Coronary Artery Disease (CAD) (Ischemic Heart Disease)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chronic Coronary Artery Disease (CAD) (Ischemic Heart ...

Jan, 2015 39 pages
Vasculitis - Pipeline Review, H1 2015 US$ 2,000.00

... Vasculitis - Pipeline Review, H1 2015’, provides an overview of the Vasculitis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Vasculitis, complete with comparative analysis at various stages, therapeutics assessment ...

Jan, 2015 105 pages
Global Rising Stars Outlook 2015: Innovative Therapies for Treating Diseases are Being Sought after with Fresh Vigor as New Targets US$ 2,000.00 US$ 1,800.00

Innovative Therapies for treating diseases ... in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added ... Criteria for Our Selection are:- Uniqueness of the Technology platform and the ability to scale up commercially in case of positive ...

Jan, 2015 72 pages
Tardive Dyskinesia - Pipeline Review, H1 2015 US$ 2,000.00

Tardive Dyskinesia - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Tardive Dyskinesia - Pipeline Review, H1 2015’, provides an overview of the Tardive Dyskinesia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Tardive Dyskinesia ...

Jan, 2015 52 pages
Chlamydia Trachomatis Infections - Pipeline Review, H1 2015 US$ 2,000.00

... Chlamydia Trachomatis Infections - Pipeline Review, H1 2015’, provides an overview of the Chlamydia Trachomatis Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Chlamydia Trachomatis Infections ...

Jan, 2015 38 pages
Speech Therapists & Audiologists Lines World Report US$ 2,950.00 Jan, 2015 2146 pages
1 2 3 4 5 >
Skip to top